Reumatologi i primärvård - Landstinget Sörmland

Innehållsförteckning
Inledning ................................................................................................................................3
Ansvarsfördelning mellan primärvården och reumatologklinik ......................................4
Utredning av ledsymtom ......................................................................................................5
Laboratorieutredning artrit ................................................................................................6
Ledpunktion ......................................................................................................................7
Klinisk immunologi vid reumatiska sjukdomar ..................................................................8
Reumatoid artrit ...................................................................................................................10
Fibromyalgi ..........................................................................................................................12
Gikt .......................................................................................................................................15
Sarkoidos .............................................................................................................................15
Artros ....................................................................................................................................16
Spondartriter ........................................................................................................................17
Mb Bechterew ................................................................................................................17
Reaktiv artrit ...................................................................................................................18
Psoriasisartrit ..................................................................................................................18
Inflammatoriska systemsjukdomar ...................................................................................19
1. PMR/TA ......................................................................................................................19
2. SLE .............................................................................................................................21
3. Sjögrens syndrom ......................................................................................................22
4. Systemisk skleros .......................................................................................................23
5. MCTD .........................................................................................................................23
6. Myositer ......................................................................................................................24
7. Vaskulitsjukdomar ......................................................................................................25
Henoch-Schönleins purpura .............................................................................25
Wegeners granulomatos ..................................................................................25
Mikroskopisk polyangit ......................................................................................25
Churg-Strauss vaskulit ......................................................................................25
Kryoglobulinemivaskulit.....................................................................................25
Takayasus arterit...............................................................................................25
Temporalisarterit................................................................................................19
Polyarteritis nodosa (PAN) ................................................................................25
Goodpasture’s disease .....................................................................................26
Behςets sjukdom ...............................................................................................26
Kutan leukocytopklastisk vaskulit ......................................................................26
Läkemedel ............................................................................................................................27
NSAID ............................................................................................................................27
Glukokortikosteroider .....................................................................................................28
Abatacept .......................................................................................................................29
Anakinra .........................................................................................................................29
Antimalariamedel ............................................................................................................30
Azatioprin ........................................................................................................................30
Cyclophosphamide .........................................................................................................31
Cyklosporin .....................................................................................................................31
Enbrel .............................................................................................................................32
Humira.............................................................................................................................32
Leflunomid ......................................................................................................................32
Methotrexate ..................................................................................................................32
Mykofenolatmofetil .........................................................................................................33
Remicade .......................................................................................................................33
Rituximab .......................................................................................................................33
Sulfasalazin ....................................................................................................................34
Vaccinationer .......................................................................................................................34
2